About
Ofer Gonen is the Chief Executive Officer of Clal Biotechnology Industries.He Previously worked at Cactus Acquisition Corp as the Chief Executive Officer.Ofer Gonen attended Tel Aviv University in 1996. Ofer Gonen is the Chief Executive Officer of Clal Biotechnology Industries Ltd. (TASE: CBI) and Cactus Acquisition Corp. 1 (Nasdaq: CCTS). Mr. Gonen has more than 20 years of experience in managing life science investments and business collaborations in both the US and Israel. Mr. Gonen serves as a board member of several private and publicly-traded portfolio companies of CBI, including Gamida Cell (Nasdaq: GMDA), MediWound (Nasdaq: MDWD) and Cactus (Nasdaq: CCTS), as well as a managing partner at the Anatomy Medical Fund. Before joining CBI, Mr. Gonen was the General Manager of Biomedical Investments Ltd., a partner at Arte Venture Group, as well as a technology consultant to various Israeli venture capital funds. Mr. Gonen gained extensive experience in R&D and management of defens
Position in the VCSift Database
- • 2 investors at Clal Biotechnology Industries are tracked.
- • 3,360 investors hold the CEO role in VCSift. Ofer Gonen is one of them.
- • 100 investors are based in Tel Aviv, Israel.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Tel Aviv, Israel
Contact Information
Find more investors like Ofer
Search Investors